Calcium channel blockers, verapamil and cancer risk

European Journal of Cancer

Volumn 39, Issue 1, 2003, Pages 7-8

  La Vecchia, C ^a,b   Bosetti, C ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; VERAPAMIL;

BREAST CARCINOMA; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CLINICAL RESEARCH; COLON CARCINOMA; CONFIDENCE INTERVAL; DATA BASE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; EDITORIAL; FOLLOW UP; HUMAN; KIDNEY CANCER; LUNG CARCINOMA; MULTIVARIATE ANALYSIS OF VARIANCE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SKIN CARCINOMA; URINARY TRACT CARCINOMA;

AGED; CALCIUM CHANNEL BLOCKERS; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; VERAPAMIL;

EID: 0037213978     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00532-4     Document Type: Editorial

References (11)

1. Beiderbeck-Noll AB, Sturkenboom MCJM, van der Linden PD, et al. Verapamil is associated with an increased risk of cancer in the elderly. Eur J Cancer (in press).
2. Levi F., Franceschi S., Te V.C., Randimbison L., La Vecchia C. Trends of skin cancer in the Canton of Vaud, 1976-1992. Br J Cancer. 72:1995;1047-1053.
3. McLaughlin J.K., Chow W.H., Mandel J.S. et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 63:1995;216-221.
4. Tavani A., La Vecchia C. Epidemiology of renal-cell carcinoma. J Nephrol. 10:1997;1-14.
5. McLaughlin J.K., Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol. 27:2000;115-123.
6. Taubes G. Epidemiology faces its limits. Science. 269:1995;164-169.
7. Trichopoulos D. The future of epidemiology. BMJ. 313:1996;436-437.
8. Pahor M., Guralnik J.M., Ferrucci L.et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 348:1996;493-497.
9. Michels K.B., Rosner B.A., Walker A.M.et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women. Cancer. 83:1998;2003-2007.
10. Jick H., Jick S., Derby L.E., Vasilakis C., Myers M.W., Meier C.R. Calcium-channel blockers and risk of cancer. Lancet. 349:1997;525-528.
11. Rosenberg L., Rao R.S., Palmer J.R.et al. Calcium channel blockers and the risk of cancer. JAMA. 279:1998;1000-1004.